Kintsugi Therapeutics
About:
Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.
Website: http://kintsugitx.com/es/
Top Investors: Capital Cell
Description:
Kintsugi Therapeutics is a preclinical biopharmaceutical company that specializing in the development of therapies for the treatment of liver conditions and other pathologies. They also develop ER stress inhibitor for the treatment of liver disease.
Total Funding Amount:
986000 EUR
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2019-01-01
Contact Email:
info(AT)kintsugitx.com
Founders:
Carmen Herrero, Marc Cusachs
Number of Employees:
1-10
Last Funding Date:
2021-11-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai